Build a Wearable EEG Seizure Detection and Prediction System

1. 1

   Start with reliable detection before promising prediction

   Detecting a seizure that is happening is hard; predicting one hours before it happens is far harder and scientifically unsettled. Build and validate reliable detection first, because a device that flags seizures accurately for clinician review already has real value. Some platforms aim to predict seizures up to four hours before onset, but stake your first product on what you can prove. Overpromising prediction and missing erodes the clinician and patient trust the whole business depends on.

2. 2

   Solve the wearable EEG hardware problem

   Capturing clinically useful EEG from a comfortable, wireless, wearable device that a person will actually keep on is a serious engineering challenge, because home signals are noisy and adherence is everything. Get the electrode, comfort, battery, and data-integrity design right so the AI has good signal to work with. The best algorithm cannot compensate for a device patients will not wear or that produces unusable data, so hardware adherence is a first-order problem.

3. 3

   Build the AI layer and manage false alarms

   The AI flags potential seizures for clinician review, and its usefulness lives and dies on the balance between catching real events and not crying wolf. Too many false alarms and clinicians and patients stop trusting and using it; too few and you miss the events that matter. Tune, validate, and clearly communicate the AI's role as assisting clinician review rather than replacing clinical judgment. This claim boundary also shapes your regulatory pathway.

4. 4

   Design the device-plus-subscription model

   The revenue model pairs a device sale with a recurring subscription for the AI analysis and monitoring service, which is what makes this more than a one-time hardware sale. Decide your split between home-use consumer pathways and hospital-grade monitoring, since they have different buyers, price points, and reimbursement. Build the recurring service so its ongoing value (continuous monitoring, alerts, clinician dashboards) justifies the subscription month after month.

5. 5

   Clear the FDA and prove clinical value

   Depending on claims, the device and its AI are regulated, and seizure-detection or prediction claims require FDA clearance and clinical evidence before clinical use. Engage regulatory strategy early and fund a 3-to-6-year runway. Prove that the system reduces harm or improves management (fewer missed seizures, better data for medication decisions) because that clinical value is what earns reimbursement and adoption. This card is distinct from the hardware-first wireless ambulatory EEG device company (a Tier 1 card): here the AI subscription and prediction ambition are the center of gravity.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: Funded teams combining wearable-hardware, EEG signal-processing, and machine-learning expertise

Not for: This is not for an unfunded founder or a pure software team without hardware capability. It is a fused hardware-AI-regulatory venture with lower viability, and it is distinct from both the Tier 1 wireless ambulatory EEG device company and the EEG foundation-model card, which is a pure SaMD algorithm play.